Tau at least partially mediates Aβ-induced BDNF downregulation. Therefore, Alzheimer’s disease treatments targeting Aβ alone may not be effective without considering the impact of Tau pathology on neurotrophic pathways. This evidence concerns the gene BDNF and Alzheimer disease.